1st Quarter - Report

ESHAM STRATEGIES LLC for ALLIANCE FOR A STRONGER FDA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues related to FDA Congressional Budget/Appropriations

LobbyistCovered position, as disclosed
ELIZABETH CARTIER ESHAM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.